|
Market Closed -
Nasdaq Stockholm
10:30:00 20/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 13.00 SEK | -0.91% |
|
-1.66% | -42.48% |
| 18/11 | Synact Pharma's CEO Jeppe Øvlesen buys shares for 0.3m kronor | FW |
| 18/11 | Synact Pharma draws remaining SEK50m under financing agreement | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
















